Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology
Fraisinib:一种杯吡咯衍生物,可在体内减少 A549 细胞衍生的 NSCLC 肿瘤,并充当甘氨酸-tRNA 合酶的配体,这是肿瘤学中的一种新分子靶点
期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2023.1258108
Iméne Ben Toumia #, Tiziana Bachetti #, Leila Chekir-Ghedira, Aldo Profumo, Marco Ponassi, Alessandro Di Domizio, Alberto Izzotti, Salvatore Sciacca, Caterina Puglisi, Stefano Forte, Raffaella Giuffrida, Cristina Colarossi, Danilo Milardi, Giuseppe Grasso, Valeria Lanza, Stefano Fiordoro, Giacomo Dr